Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 4 of 4 descriptions
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Tralokinumab (D09979) | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
(D09979) 💬1. Tralokinumab
| 1件: IL13 IL13 💬1. Tralokinumab
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling ... | 2件: 85 85, 97 💬
| ||||||||||||||
2 | Tralokinumab cohort 1 (D09979) | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
(D09979) 💬2. Tralokinumab cohort 1
| 1件: IL13 IL13 💬2. Tralokinumab cohort 1
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling ... | 1件: 85 85 💬2. Tralokinumab cohort 1
| ||||||||||||||
3 | Tralokinumab cohort 2 (D09979) | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
(D09979) 💬3. Tralokinumab cohort 2
| 1件: IL13 IL13 💬3. Tralokinumab cohort 2
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling ... | 1件: 85 85 💬3. Tralokinumab cohort 2
| ||||||||||||||
4 | Tralokinumab is a human recombinant monoclonal antibody (MAb) of the subclass that specifically binds human IL-13, blocking interactions with the IL-13 receptor (D09979) Tralokinumab is a human recombinant monoclonal antibody (MAb) of the subclass that specifically bind ... | 1件: Tralokinumab Tralokinumab | 1件: Tralokinumab
Tralokinumab
(D09979) 💬4. Tralokinumab is a human recombinant monoclonal antibody (MAb) of the subclass that specifically binds human IL-13, blocking interactions with the IL-13 receptor
| 1件: IL13 IL13 💬4. Tralokinumab is a human recombinant monoclonal antibody (MAb) of the subclass that specifically binds human IL-13, blocking interactions with the IL-13 receptor
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling ... | 1件: 85 85 💬4. Tralokinumab is a human recombinant monoclonal antibody (MAb) of the subclass that specifically binds human IL-13, blocking interactions with the IL-13 receptor
|